Patents Represented by Attorney David R. Saliwanchik
  • Patent number: 4923807
    Abstract: The invention is directed to an Arg-Serpin human plasminogen activator inhibitor designated PAI-2. This protein is prepared via recombinant DNA means. The invention also includes other serpins which can be made by amino acid substitutions or deletions in conserved regions of PAI-1 and PAI-2, as shown in FIG. 4. The proteins of the invention can be used to inhibit, or at least modulate, human plasminogen activator activity in a variety of physiological conditions, e.g., fibrinolysis, tumor metastasis, and tumor growth.
    Type: Grant
    Filed: February 6, 1987
    Date of Patent: May 8, 1990
    Assignees: New England Medical Center Hospitals Inc., Tufts College, Wellesley College, MIT
    Inventors: Andrew C. Webb, Philip E. Auron
  • Patent number: 4919924
    Abstract: The subject invention enables a more efficient management of hair by providing a novel preparation for waving, straightening, softening, or removing hair, employing as a key ingredient the compound thioredoxin or a thioredoxin-derived, or thioredoxin-like, dithiol peptide in combination with thioglycolic acid compounds. This invention allows hair to be treated at a lower pH to minimize hair damage when waving, straightening, or softening the hair; when used to remove hair, objectionable odors of commercial depilatories are minimized or eliminated.
    Type: Grant
    Filed: August 28, 1985
    Date of Patent: April 24, 1990
    Assignee: Repligen Corporation
    Inventor: Vincent P. Pigiet
  • Patent number: 4910016
    Abstract: The subject invention concerns a novel and useful insecticide with activity against insect pests of the order Coleoptera and the order Lepidoptera. Pests in the order Coleoptera do heavy damage to crops, e.g., corn. The insecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. MT 104, or mutants thereof. The spores or crystals of this microbe are useful to control coleopteran and lepidopteran pests in various environments.
    Type: Grant
    Filed: August 3, 1987
    Date of Patent: March 20, 1990
    Assignee: Mycogen Corporation
    Inventors: Frank H. Gaertner, George G. Soares, Jewel Payne
  • Patent number: 4910136
    Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository.
    Type: Grant
    Filed: February 11, 1988
    Date of Patent: March 20, 1990
    Assignee: Mycogen Corporation
    Inventors: Corinna Herrnstadt, Edward Wilcox
  • Patent number: 4904602
    Abstract: The subject invention concerns a novel enzyme named thioredoxin shufflease, means for preparing the same, and procedures for using thioredoxin shufflease to fold proteins containing disulfide crosslinks. Thioredoxin shufflease is a generic term to define enzymes which have the following characteristics: (a) contain a single reactive thiol group; (b) catalyze the exchange of disulfides in a protein undergoing the refolding process; and (c) are not consumed in the oxidation/refolding process. Specifically exemplified is a thioredoxin shufflease produced from an E. coli thioredoxin gene.
    Type: Grant
    Filed: August 8, 1986
    Date of Patent: February 27, 1990
    Assignee: Repligen Corporation
    Inventors: Vincent P. Pigiet, James R. Rusche, Barbara J. Schuster
  • Patent number: 4894223
    Abstract: The subject invention enables a more efficient management of hair by providing a novel preparation for waving, straightening, softening, or removing hair, employing as a key ingredient the compound thioredoxin or a thioredoxin-derived, or thioredoxin-like, dithiol peptide in combination with a sulfite or bisulfite compound.
    Type: Grant
    Filed: January 4, 1988
    Date of Patent: January 16, 1990
    Assignee: Repligen Corporation
    Inventor: Vincent P. Pigiet
  • Patent number: 4888280
    Abstract: Hybrid useful proteins are prepared by a novel biological system comprising a prokaryotic host transformed with novel hybrid plasmids' .beta.-glucuronidase (BG) gene DNZ and the desired protein gene DNA. Specifically exemplified are plasmids which comprise BG gene DNA and protein A DNA. E. coli K-12 derivative hosts transformed with plasmid pBG3-2.DELTA.n express >60% of the desired fusion protein having protein A-like biological activity. Other useful proteins can be expressed via the elegant highly efficient expression system of the subject invention.
    Type: Grant
    Filed: August 25, 1986
    Date of Patent: December 19, 1989
    Assignee: Repligen Corporation
    Inventors: John L. Palmer, Algis Anilionis
  • Patent number: 4871386
    Abstract: The subject invention concerns a novel bioherbicide and its use to control major weeds found in many fields in the United States. Specifically, Alternaria euphorbiicola Simmons and Engelhard, having the identifying characteristics of culture deposit NRRL 18227, in an agricultural composition, can be used to effectively control wild poinsettia and weedy spurges. Further, Alternaria euphorbiicola Simmons and Engelhard, having the idenfifying characteristics of deposit NRRL 18227, in a mixture with Alternaria cassiae, can be used to control wild poinsettia and weedy spurges and other undesired vegetation, such as sicklepod, showy crotalaria, and coffee senna. Further, the bioherbicide of the invention can be mixed with a chemical herbicide to increase weed control.
    Type: Grant
    Filed: July 6, 1987
    Date of Patent: October 3, 1989
    Assignee: Mycogen Corporation
    Inventor: Joe A. Riley
  • Patent number: 4865981
    Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository.
    Type: Grant
    Filed: August 16, 1985
    Date of Patent: September 12, 1989
    Assignee: Mycogen Corporation
    Inventors: Corinna Herrnstadt, Edward Wilcox
  • Patent number: 4861595
    Abstract: A biological delivery system particularly suited for delivery of protein compounds to animals and humans is disclosed. The system uses a producing microbe itself after suitable treatment by chemical and/or physical means. The product being delivered is contained within the treated microbial cell; it is produced intracellularly by a homologous (native) gene.
    Type: Grant
    Filed: September 11, 1987
    Date of Patent: August 29, 1989
    Assignee: Mycogen Corporation
    Inventors: Andrew C. Barnes, David L. Edwards
  • Patent number: 4855304
    Abstract: Potent plant antivirals are disclosed along with their method of use. These antivirals, 5',5'- or 2',5'- or 3',5'-pyrophosphorylated-dinucleotides, are specifically shown to inhibit tobacco mosaic virus (TMV) replication in tobacco plants when applied to the leaves or through the roots of these plants. These antiviral compounds can also be used to treat a variety of other plants, as disclosed herein, which are susceptible to a broad range of viruses.
    Type: Grant
    Filed: October 10, 1985
    Date of Patent: August 8, 1989
    Assignee: Repligen Corporation
    Inventor: Yair Devash
  • Patent number: 4853331
    Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository. The microbe is now known as B. thuringiensis strain san diego.
    Type: Grant
    Filed: November 30, 1988
    Date of Patent: August 1, 1989
    Assignee: Mycogen Corporation
    Inventors: Corinna Herrnstadt, Edward Wilcox
  • Patent number: 4849217
    Abstract: Novel Bacillus thuringiensis (B.t.) isolates are disclosed and claimed. These novel B.t. isolates have activity against the Egyptian alfalfa weevil, which is known to cause heavy agricultural losses.
    Type: Grant
    Filed: November 19, 1987
    Date of Patent: July 18, 1989
    Assignee: Mycogen Corporation
    Inventors: George G. Soares, Robert C. Everich, Jewel Payne
  • Patent number: 4845031
    Abstract: The subject invention concerns a process for stabilizing foreign proteins within the cell of E. coli microbes infected with genetic elements encoding said protein production.
    Type: Grant
    Filed: August 23, 1985
    Date of Patent: July 4, 1989
    Assignee: The Research Foundation of State University of New York
    Inventors: David A. Shub, Nancy J. Casna
  • Patent number: 4833086
    Abstract: The subject invention concerns a novel plasmid and its use in a microbial host to degrade a variety of organic compounds. Some of these compounds, such as ethylene dichloride, are undesirable waste products found in various dump sites. The invention also concerns a novel microbe hosting the novel plasmid. The novel plasmid has been shown to encode the gene(s) responsible for the degradation of the organic compounds. Thus, microbes hosting this plasmid, denoted pEDC, can be used to degrade ethylene dichloride, and other compounds.
    Type: Grant
    Filed: March 21, 1986
    Date of Patent: May 23, 1989
    Assignee: The B F Goodrich Company
    Inventor: Amikam Horowitz
  • Patent number: 4814744
    Abstract: A method and apparatus for detecting low air pressure in pneumatic tires on a vehicle and conveying this information to the operator of the vehicle. The invention utilizes a resonating device which creates subsonic, sonic, or ultrasonic air waves when it comes in contact with the rotating sidewall of a tire having undesirably low air pressure. The apparatus provides immediate, dependable warning of potentially dangerous low pressure conditions in tires. Furthermore, the apparatus can be used to detect low air pressure in either of dual mounted tires.
    Type: Grant
    Filed: December 1, 1987
    Date of Patent: March 21, 1989
    Assignee: Collins Design Company, Inc.
    Inventor: Jerry L. Collins
  • Patent number: 4808207
    Abstract: Disclosed are compositions and processes for controlling undesirable weeds. These compositions comprise synergistic combinations of microbial herbicides and or plant growth regulators. Use of the synergistic compositions of the subject invention enhances the value of the microbial herbicide by reducing the amount of microbial herbicide needed and by extending the range of environmental conditions in which the microbial herbicide will function.
    Type: Grant
    Filed: October 28, 1987
    Date of Patent: February 28, 1989
    Assignees: The University of Vermont and State Agricultural College, The Royal Institution for the Advancement of Learning (McGill University)
    Inventors: Alan R. Gotlieb, Alan K. Watson
  • Patent number: 4806482
    Abstract: The subject invention concerns a novel plasmid and its use in a microbial host to degrade a variety of organic compounds. Some of these compounds, such as ethylene dichloride, are undesirable waste products found in various dump sites. The invention also concerns a novel microbe hosting the novel plasmid. The novel plasmid has been shown to encode the gene(s) responsible for the degradation of the organic compounds. Thus, microbes hosting this plasmid, denoted pEDC, can be used to degrade ethylene dichloride, and other compounds.
    Type: Grant
    Filed: June 6, 1988
    Date of Patent: February 21, 1989
    Assignee: The B.F. Goodrich Company
    Inventor: Amikam Horowitz
  • Patent number: 4797276
    Abstract: The subject invention concerns a novel and useful insecticide with activity against insect pests of cotton, potato, alfalfa and corn crops. These pests do heavy damage to the crops. The insecticide of the subject invention is a B. thuringiensis microbe given the designation strain san diego. The spores or crystals of this microbe are useful to control the cotton boll weevil, the Colorado potato beetle, the alfalfa weevil, and the corn rootworm.
    Type: Grant
    Filed: March 21, 1986
    Date of Patent: January 10, 1989
    Assignee: Mycogen Corporation
    Inventors: Corinna Herrnstadt, George G. Soares
  • Patent number: 4786631
    Abstract: The invention concerns novel AVP-binding peptides having the formula:Thr-Met-X-Val-Leu-Thr-Gly-Ser-Pro-Bwherein X is selected from the group consisting of Lys, Arg, and Asp; B is OH, NH.sub.2, NHAlk, wherein Alk is lower alkyl of 1-4 carbons, inclusive. These peptides block AVP function, and, therefore, are useful in many areas among which is the control of hypertension.
    Type: Grant
    Filed: March 18, 1988
    Date of Patent: November 22, 1988
    Assignee: University of Florida
    Inventors: Howard M. Johnson, Barbara A. Torres